Clinical trial
Evaluate the Efficacy of Insulin Patients With Type 1 Diabetes
NCT00356109 · Eli Lilly and Company, Industry · Completed
Key facts
| NCT number | NCT00356109 |
|---|---|
| Title | Evaluate the Efficacy of Insulin Patients With Type 1 Diabetes |
| Official title | A Phase 3, Open-Label, Parallel-Group Study to Evaluate the Efficacy of Preprandial Human Insulin Inhalation Powder (HIIP) Compared to Preprandial Injectable Insulin in Patients With Type 1 Diabetes Mellitus |
| Lead sponsor | Eli Lilly and Company, Industry |
| Collaborators | Alkermes, Inc. Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Diabetes Mellitus, Type 1 |
| Intervention type | Drug |
| Interventions | Human Insulin Inhalation Powder, Injectable insulin, Insulin Glargine |
| Enrollment | 494 |
| Start date | Aug 1, 2006 |
| Primary completion | May 1, 2008 |
| Completion | May 1, 2008 |
| First posted | Jul 25, 2006 |
| Last update posted | Mar 9, 2018 |
| Countries | Argentina, Belgium, France, Germany, India, Italy, Mexico, Puerto Rico, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: